Literature DB >> 1707947

Breakdown of the blood-brain barrier during dengue virus infection of mice.

U C Chaturvedi1, R Dhawan, M Khanna, A Mathur.   

Abstract

A breakdown of the blood-brain barrier occurred in mice inoculated intracerebrally (i.c.) or intraperitoneally (i.p.) with dengue virus type 2 (DEN2). This resulted in leakage of protein-bound Evans blue dye and 51Cr-labelled erythrocytes into the brain tissue. The leakage increased with time after infection and coincided with an increase of a DEN2-induced cytokine, the cytotoxic factor (CF), in the spleens of such mice. The titres of virus in the brain increased exponentially in i.c. inoculated mice but the virus was not detected in brains of mice given DEN2 by the i.p. route. Similar breakdown of the blood-brain barrier also occurred in mice inoculated intravenously with CF; the damage was dose-dependent and the vascular integrity was restored during the 3 h period after inoculation. Treatment of mice with antihistamine drugs, blocking H1 or H2 receptors, decreased the DEN2-induced protein leakage by up to 50% in i.c. inoculated mice and up to 92% in those inoculated i.p. Indomethacin, a prostaglandin synthetase inhibitor, had no effect. In i.c. inoculated mice protein leakage was inhibited by about 60% by treatment with CF-specific (CFA) or DEN2-specific antisera (DEN2A) whereas protection was complete with the combined treatment with both antisera. On the other hand, in i.p. inoculated mice the inhibition of protein leakage was 80 to 89% with CFA. These findings show a breakdown of the blood-brain barrier leading to cerebral oedema during DEN2 infection which is mediated via the release of histamine by a virus-induced cytokine.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1707947     DOI: 10.1099/0022-1317-72-4-859

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  46 in total

1.  Potential of ancestral sylvatic dengue-2 viruses to re-emerge.

Authors:  Nikos Vasilakis; Elisabeth J Shell; Eric B Fokam; Peter W Mason; Kathryn A Hanley; D Mark Estes; Scott C Weaver
Journal:  Virology       Date:  2006-10-02       Impact factor: 3.616

2.  Identification and purification of a receptor on macrophages for the dengue virus-induced suppressor cytokine.

Authors:  R Mukherjee; P Chaturvedi; U C Chaturvedi
Journal:  Clin Exp Immunol       Date:  1993-02       Impact factor: 4.330

3.  In vivo infection by a neuroinvasive neurovirulent dengue virus.

Authors:  Myriam Lucia Velandia-Romero; Orlando Acosta-Losada; Jaime E Castellanos
Journal:  J Neurovirol       Date:  2012-07-24       Impact factor: 2.643

4.  Active immunization by a dengue virus-induced cytokine.

Authors:  U C Chaturvedi; R Mukerjee; R Dhawan
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

5.  Vesicular stomatitis virus infection of the central nervous system activates both innate and acquired immunity.

Authors:  Z Bi; M Barna; T Komatsu; C S Reiss
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

Review 6.  West Nile virus and its emergence in the United States of America.

Authors:  Kristy O Murray; Eva Mertens; Philippe Despres
Journal:  Vet Res       Date:  2010 Nov-Dec       Impact factor: 3.683

7.  Depression of chemiluminescence during dengue virus infection of mice: role of cytokines.

Authors:  R Dhawan; U C Chaturvedi; K N Mashihi; P Chaturvedi; R Mukherjee
Journal:  Int J Exp Pathol       Date:  1993-10       Impact factor: 1.925

8.  New mouse model for dengue virus vaccine testing.

Authors:  A J Johnson; J T Roehrig
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

9.  Infection of pericytes in vitro by Japanese encephalitis virus disrupts the integrity of the endothelial barrier.

Authors:  Chun-Jung Chen; Yen-Chuan Ou; Jian-Ri Li; Cheng-Yi Chang; Hung-Chuan Pan; Ching-Yi Lai; Su-Lan Liao; Shue-Ling Raung; Chen-Jung Chang
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

Review 10.  Dengue viral infections.

Authors:  G N Malavige; S Fernando; D J Fernando; S L Seneviratne
Journal:  Postgrad Med J       Date:  2004-10       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.